Presented at AGBT 2020: UtraSensitive Residual Leukemia Detection with Patient-Specific Duplex Sequencing

Jesse Salk, MD, PhD, is the CEO and CSO of TwinStrand Biosciences. He explains the challenges of finding a genetic needle in a haystack and shares how Twist's technology and target enrichment solutions help him achieve the otherwise "crazy" results he's seeking from patient samples using duplex sequencing.

watch Webinar